Sulzer Ag · SIX:SUN
Sulzer — Merger or Acquisition (May 2021)
11 slides from Sulzer's merger presentation, May 27, 2021
Slide 1: Spin-off of APS as medmix
Spin-off of APS as Greg Poux-Guillaume, CEO | Jill Lee, CFO | May 27, 2021
Slide 2: Disclaimer
Disclaimer This presentation contains forward-looking statements, including but not limited to, projections of financial developments, market activities, future performance of products and solutions or planned transactions, containing risks and uncertainties. These forward- looking statements are su
Slide 3: Incubator of innovative technologies since 1834
Incubator of innovative technologies since 1834 Pumps since 1834 Heating and Air Condition 1841 – 2001 Thermal energy systems 1841 – 1997 Steam engines 1854 – 1952 Shipbuilding 1867 – 1934 Rock drilling machine / Tunneling 1876 – 1905 Refrigeration systems 1877 – 2001 Reciprocating compressors 1878
Slide 4: Transaction summary
Transaction summary ▪ Sulzer has built APS into a leader in high-precision delivery devices, now well positioned to succeed and grow as an independent entity ▪ Sulzer has also significantly diversified its core portfolio, shifting away from energy towards water, chemicals and biopolymers, and a uniq
Slide 5: Transaction rationale
Transaction rationale Two focused leaders for attractive end-markets Flow control specialist for water, chemical, industry and energy Innovative, high-precision delivery devices • A global leader in industrial flow control • Leading positions in dental, pharma, adhesives and beauty • Continuous shif
Slide 6: medmix snapshot
snapshot Innovative, high-precision delivery devices serving attractive markets Healthcare Consumer and Industrial Drug Dental Surgery Industry Beauty delivery Gold standard in Award winning, Pioneer in bone Leader in industrial Leading dental mixing proprietary injection cement mixing mixing and di
Slide 7: Vision for medmix
Vision for Diversified exposure to growing end-markets, with healthcare segments growing fastest ✓ • Attractive and resilient B2B niche markets Niche leader • Exciting underlying macro growth trends • Fragmented competitive landscape ✓ • High entry barriers, e.g. regulation Highly • High IP protecti
Slide 8: Vision for Sulzer
Vision for Sulzer Accelerate repositioning towards sustainable applications and push aftermarket > 50% ✓ Capitalize on leadership in high-barrier-to-entry markets through Sulzer’s technology, service capabilities and proven digital advance ✓ Focus on sustainable sectors for mid-term growth, e.g. Wat
Slide 9: Indicative transaction timetable
Indicative transaction timetable 15-Jun-2021 2021 Capital Markets Day 22-Jul-2021 Publication of H1 2021 results Late Q3 2021 Extraordinary Shareholder Meeting H2 2021 Spin-off and capital increase / first trading day of medmix at SIX 9
Slide 10: Key takeaways
Key takeaways ▪ Split into two focused companies with different end-markets via a separate stock market listing of medmix ▪ While medmix will focus on healthcare and further develop its industrial and consumer markets, Sulzer will become a pure play industrial flow control company ▪ Transaction to l
Slide 11: Your Investor Relations contact
Your Investor Relations contact Christoph Ladner Head of Investor Relations Sulzer Management Ltd Phone: +41 52 262 30 22 Neuwiesenstrasse 15 Mobile: +41 79 326 69 70 8401 Winterthur E-mail: christoph.ladner@sulzer.com Switzerland www.sulzer.com